On (b)(6) 2019, an email was received from an optical shop representative in (b)(6) who reported a patient (pt) was diagnosed with a corneal ulcer while wearing an acuvue brand contact lens (cls).On (b)(6) 2019, a call was placed to the pt and additional information was provided: the pt reported on (b)(6) 2019 after 3 weeks of wearing the acuvue oasys brand contact lens, the right eye (od) became painful and red.The pt reported the suspect cl was removed immediately.On removal of the od cl the pt reported eye pain, like a knife stabbing in the eye.The pt also noticed a ¿little spot¿ on the od at about 3 o¿clock.The pt went to an eye care provider (ecp) on (b)(6) 2019 and was diagnosed with an od corneal ulcer.The pt was prescribed cilodex every 2 hours for 2 days, then every 3 hours for 7 days.The pt was also prescribed epitegel to use nightly until the ecp return visit on (b)(6) 2019.The pt reported that once the medication was started, the symptoms improved by (b)(6) 2019.The pt reports that the ¿small spot¿ on the od is slightly smaller and experiences a burning sensation.The pt is currently wearing glasses and the ecp recommends the pt not return to cls wear.The pt replaces the cls ¿within less than 3 months of wear¿ and does not sleep in the cls.The pt can¿t recall which cl solution is used to disinfect the cls.On (b)(6) 2019, a call was placed to the pt¿s treating ecp and additional medical information was provided: the pt was diagnosed with an infectious peripheral corneal ulcer at 9 o¿clock.On the last visit on (b)(6) 2019, the corneal ulcer was not completely healed but has improved.Treatment continues with cilodex every 3 hours and epitegel tid.The ecp reported that once the corneal ulcer resolves, the pt will be re-evaluated for a return to cl wear.No additional medical information was provided.On (b)(6) 2019, a call was placed to the pt and additional information was provided: the pt has a follow-up appointment with the ecp on (b)(6) 2019 and has not been released to return to cl wear.Pt advised that the od feels better and the ¿spot¿ on the eye is very small.On (b)(6) 2019, a call was placed to the pt and additional information was provided: the pt visited the ecp today and was released from care and allowed to return to cl wear.The pt was advised to continue using lubricating drops.The pt was informed by the ecp that there is a scar on the od.The pt reported that the od is no longer painful and feels much better.The suspect product was requested for return for evaluation, but it has not yet been received.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot l003ksr was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
|